US 8222222
Compositions and methods for inhibiting expression of the PCSK9 gene
granted A61KA61K31/713A61P
Quick answer
US patent 8222222 (Compositions and methods for inhibiting expression of the PCSK9 gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/713, A61P, A61P3/06, A61P43/00